Page last updated: 2024-08-25

picropodophyllin and B16 Melanoma

picropodophyllin has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
All-Ericsson, C; Aström, K; Axelson, M; Economou, MA; Girnita, A; Girnita, L; Larsson, O; Seregard, S	1

Other Studies

1 other study(ies) available for picropodophyllin and B16 Melanoma

Article	Year
The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells. Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Feb-15, Volume: 12, Issue:4 Topics: Animals; Blotting, Western; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Humans; Melanoma; Melanoma, Experimental; Mice; Mice, SCID; Neoplasm Invasiveness; Phosphorylation; Podophyllotoxin; Receptor, IGF Type 1; Uveal Neoplasms; Xenograft Model Antitumor Assays	2006

Article

Year

The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Feb-15, Volume: 12, Issue:4

Topics: Animals; Blotting, Western; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Humans; Melanoma; Melanoma, Experimental; Mice; Mice, SCID; Neoplasm Invasiveness; Phosphorylation; Podophyllotoxin; Receptor, IGF Type 1; Uveal Neoplasms; Xenograft Model Antitumor Assays

2006